AMERICAN CENTURY COMPANIES INC
Position in LKFT — Lakefront Biotherapeutics NV
CIK 748054
KANSAS CITY, MO
Position in LKFT
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$1,223,303
+$59,603 QoQ
Shares Held
40,804
+5.2% QoQ
Ownership
0.062%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#21
of 78 holders
Holding Since
Mar 2020
21 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LKFT Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026AMERICAN CENTURY COMPANIES INC holds $3,568,452,939 across 178 Biotechnology names. LKFT ranks #83 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
1,853,956 | $558,096,374 | |
| 2 | ASND |
Ascendis Pharma A/S
|
1,400,575 | $373,561,364 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
580,901 | $288,550,953 | |
| 4 | ARGX |
Argenx SE
|
173,193 | $160,683,269 | |
| 5 | IONS |
Ionis Pharmaceuticals Inc
|
1,947,076 | $154,383,656 | |
| 6 | EXEL |
Exelixis, Inc.
|
1,791,664 | $97,484,438 | |
| 7 | HRMY |
Harmony Biosciences Holdings, Inc.
|
2,539,512 | $92,463,631 | |
| 8 | GPCR |
Structure Therapeutics Inc.
|
1,682,179 | $90,282,546 |
All Filings in LKFT
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,223,303 | 40,804 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $1,163,700 | 38,790 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $874,038 | 26,729 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $956,167 | 27,603 | Shares | Defined | 2025-11-12 | |
| 2025-06-30 | $786,574 | 28,102 | Shares | Defined | 2025-08-12 | |
| 2025-03-31 | $699,315 | 27,839 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $710,930 | 25,852 | Shares | Defined | 2025-02-11 | |
| 2024-09-30 | $703,080 | 24,421 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $587,558 | 23,711 | Shares | Defined | 2024-08-07 | |
| 2024-03-31 | $763,494 | 23,711 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $954,096 | 23,471 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $764,487 | 22,127 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $415,138 | 10,210 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $353,865 | 9,158 | Shares | Defined | 2023-05-11 | |
| 2022-12-31 | $402,881 | 9,078 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $383,845 | 9,002 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $499,131 | 8,945 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $415,968 | 6,707 | Shares | Defined | 2022-05-11 | |
| 2020-09-30 | $228,617 | 1,611 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $309,942 | 1,571 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $222,956 | 1,138 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||